This National Institutes of Health grant is offered to expand the HIV/AIDS prevention toolkit for populations impacted by alcohol use, spanning various patterns of use and associated behavioral and biological risks for HIV acquisition. The purpose is to integrate effective prevention and treatment interventions, facilitating cross-cutting research to reduce new infections. This research activity encompasses the development and testing of novel interventions and the expansion of existing effective strategies, alongside their implementation in diverse settings and populations. Primary interest areas include PrEP utilization, Treatment as Prevention (TasP), integration of preventive intervention strategies, prevention-related cross-cutting research, syndemic approaches, and implementation/operations research, considering mental health and substance use comorbidities.
Opportunity ID: 335381
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AA-21-016 |
| Funding Opportunity Title: | HIV Prevention and Alcohol (R01 Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 20, 2021 |
| Last Updated Date: | Aug 20, 2021 |
| Original Closing Date for Applications: | Dec 16, 2021 |
| Current Closing Date for Applications: | Dec 16, 2021 |
| Archive Date: | Jan 21, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public housing authorities/Indian housing authorities State governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Special district governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with an understanding of the overarching framework for reducing the incidence of new infections by facilitating cross-cutting informative research. This research activity includes the development and testing of new interventions and expansion of existing effective interventions as well as the implementation of these integrative preventive activities in diverse settings and populations. Six areas of research are of primary interest related to alcohol use and related mental health and substance use comorbidities. These include but are not limited to 1) PrEP Utilization, 2) Treatment as Prevention (TasP), 3) Integration of Preventive Intervention Strategies, 4) Prevention-related Cross-cutting Research, 5) Syndemic Approaches and, 6) Implementation and Operations Research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-21-016.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269820 | Nov 16, 2021 | Dec 16, 2021 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268657 | Nov 16, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
335381 RR_SF424_5_0-5.0.pdf
335381 PHS398_CoverPageSupplement_5_0-5.0.pdf
335381 RR_OtherProjectInfo_1_4-1.4.pdf
335381 PerformanceSite_4_0-4.0.pdf
335381 RR_KeyPersonExpanded_4_0-4.0.pdf
335381 PHS398_ResearchPlan_4_0-4.0.pdf
335381 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335381 RR_Budget_3_0-3.0.pdf
335381 RR_SubawardBudget30_3_0-3.0.pdf
335381 PHS398_ModularBudget_1_2-1.2.pdf
335381 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335381 RR_SF424_2_0-2.0.pdf
335381 PHS398_CoverPageSupplement_5_0-5.0.pdf
335381 RR_OtherProjectInfo_1_4-1.4.pdf
335381 PerformanceSite_2_0-2.0.pdf
335381 RR_KeyPersonExpanded_2_0-2.0.pdf
335381 PHS398_ResearchPlan_4_0-4.0.pdf
335381 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335381 RR_Budget_1_4-1.4.pdf
335381 RR_SubawardBudget30_1_4-1.4.pdf
335381 PHS398_ModularBudget_1_2-1.2.pdf
335381 PHS_AssignmentRequestForm_3_0-3.0.pdf